Research Output
Telemonitoring for chronic obstructive pulmonary disease: a cost and cost-utility analysis of a randomised controlled trial
  We compared the costs and cost-effectiveness of telemonitoring vs usual care for patients with chronic obstructive pulmonary disease (COPD). A total of 256 patients were randomised to either telemonitoring or usual care. In the telemonitoring arm, the touch-screen telemonitoring equipment transmitted data to clinical teams monitoring the patients. Total healthcare costs were estimated over a 12-month period from a National Health Service perspective and quality adjusted life year (QALYs) were estimated by the EQ-5D tool. Telemonitoring was not significantly more costly than usual care (mean difference per patient £2065.90 (P

  • Type:

    Article

  • Date:

    13 January 2015

  • Publication Status:

    Published

  • Publisher

    Sage

  • DOI:

    10.1177/1357633x14566574

  • Cross Ref:

    10.1177/1357633X14566574

  • ISSN:

    1357-633X

  • Library of Congress:

    RT Nursing

  • Dewey Decimal Classification:

    610.73 Nursing

Citation

Stoddart, A., van der Pol, M., Pinnock, H., Hanley, J., McCloughan, L., Todd, A., …McKinstry, B. (2015). Telemonitoring for chronic obstructive pulmonary disease: a cost and cost-utility analysis of a randomised controlled trial. Journal of Telemedicine and Telecare, 21(2), 108-118. https://doi.org/10.1177/1357633x14566574

Authors

Keywords

Telemonitoring; chronic obstructive pulmonary disease (COPD); cost-effectiveness;

Monthly Views:

Available Documents